Immunomedics, Inc. (NASDAQ:IMMU)
Q2 2017 Earnings Conference Call
February 10, 2017 8:00 AM ET
Executives
Michael Garone – Chief Financial Officer
David Goldenberg – Chairman and Chief Scientific Officer
Cynthia Sullivan – President and Chief Executive Officer
Brian Markison – Lead Independent Director
Jason Aryeh – Independent Vice Chairman of the Board and Chairman of the Transaction Committee
Analysts
Boris Peaker – Cowen
Jim Birchenough – Wells Fargo
Matthew Andrews – Jefferies
Nick Abbott – Wells Fargo
